Funding Boosts for Breast Cancer Research
International Clinical Trials Day on 20th May brings attention to the crucial need for increased investment in medical research, particularly in the field of breast cancer.
Dr Julia Dixon-Douglas, a recipient of the 2026 Breast Cancer Trials Clinical Fellowship Grant, is conducting pivotal research on triple-negative breast cancer. Her work aims to understand why certain patients respond to immunotherapy while others do not.
The Federal Government has announced a significant increase in funding through the Medical Research Future Fund, with disbursements rising by $508.5 million over the next four years from 2026–27. This investment will reach $1 billion annually by 2030–31.
Karen Price, CEO of Breast Cancer Trials, emphasised the importance of Dr Dixon-Douglas’s research, stating, “Dr Dixon-Douglas’ work highlights the importance of investing in clinical trials research.”
Challenges and Opportunities
Dr Dixon-Douglas explains that triple-negative breast cancer lacks the receptors typically used to guide treatment, making it more aggressive. Her research focuses on identifying biomarkers to tailor immunotherapy treatments, potentially reducing side effects.
She noted, “The idea is to understand what the patient’s immune system is doing before we start any treatment, to identify which factors will help us design the treatment that is going to suit them best.”
Dr Dixon-Douglas and her team are using new technology to track tumour response through blood tests, which reduces the need for invasive procedures. “We can track whether the tumour DNA is decreasing in the blood,” she added.
The Breast Cancer Trials organisation supports over 1,000 researchers across 118 institutions in Australia and New Zealand, aiming to prevent and treat breast cancer through clinical trials.
While the increased funding is promising, only 8% of Australian NHMRC medical research grant applications are currently successful, highlighting the competitiveness of the field.
For more information on Dr Dixon-Douglas’s research and the Breast Cancer Trials Clinical Fellowship programme, interested parties can visit the Breast Cancer Trials website.
Last updated: 29 June 2026, 12:04 pm
